| Primary |
| Anaesthesia |
17.5% |
| General Anaesthesia |
16.5% |
| Drug Use For Unknown Indication |
15.9% |
| Product Used For Unknown Indication |
15.2% |
| Maintenance Of Anaesthesia |
9.9% |
| Induction Of Anaesthesia |
5.2% |
| Surgery |
2.9% |
| Gastrectomy |
2.4% |
| Analgesic Therapy |
1.9% |
| Hysterectomy |
1.9% |
| Anaesthesia Procedure |
1.6% |
| Foetal Exposure Timing Unspecified |
1.6% |
| Pain |
1.3% |
| Prophylaxis Of Nausea And Vomiting |
1.2% |
| Prophylaxis |
1.0% |
| Premedication |
0.9% |
| Antibiotic Prophylaxis |
0.8% |
| Vascular Operation |
0.8% |
| Lymphoid Tissue Operation |
0.7% |
| Anaesthesia Reversal |
0.6% |
|
| Bradycardia |
16.4% |
| Post Procedural Complication |
15.1% |
| Foetal Exposure During Pregnancy |
6.2% |
| Hepatitis |
6.2% |
| Tachycardia |
6.2% |
| Cardiac Arrest |
5.5% |
| Congenital Anomaly |
4.1% |
| Hyperthermia Malignant |
4.1% |
| Increased Upper Airway Secretion |
4.1% |
| Laryngospasm |
4.1% |
| Anaphylactic Shock |
3.4% |
| Bronchospasm |
3.4% |
| Drug Ineffective |
3.4% |
| Blood Pressure Systolic Increased |
2.7% |
| Hypotension |
2.7% |
| Pulmonary Granuloma |
2.7% |
| Respiratory Distress |
2.7% |
| Vomiting |
2.7% |
| Chronic Hepatitis |
2.1% |
| Death |
2.1% |
|
| Secondary |
| Anaesthesia |
23.6% |
| General Anaesthesia |
19.8% |
| Drug Use For Unknown Indication |
12.5% |
| Hysterectomy |
6.1% |
| Premedication |
5.0% |
| Product Used For Unknown Indication |
5.0% |
| Gastrectomy |
3.7% |
| Prophylaxis |
3.3% |
| Vascular Operation |
2.7% |
| Pain |
2.4% |
| Cystoscopy |
2.3% |
| Ureteroscopy |
2.3% |
| Induction Of Anaesthesia |
2.1% |
| Abdominal Pain |
1.7% |
| Choledocholithotomy |
1.7% |
| Preoperative Care |
1.5% |
| Antibiotic Prophylaxis |
1.2% |
| Gastrointestinal Disorder |
1.1% |
| Maintenance Of Anaesthesia |
1.1% |
| Arterial Repair |
0.9% |
|
| Bradycardia |
26.4% |
| Renal Failure Acute |
15.4% |
| Rhabdomyolysis |
6.6% |
| Liver Function Test Abnormal |
5.5% |
| Myocardial Stunning |
5.5% |
| Shock |
5.5% |
| Cytolytic Hepatitis |
4.4% |
| Pain |
4.4% |
| Encephalopathy |
3.3% |
| Hypotension |
3.3% |
| Abdominal Pain |
2.2% |
| Hepatitis |
2.2% |
| Hepatitis Fulminant |
2.2% |
| Increased Upper Airway Secretion |
2.2% |
| Liver Injury |
2.2% |
| Respiratory Disorder |
2.2% |
| Tachycardia |
2.2% |
| Transaminases Increased |
2.2% |
| Acute Hepatic Failure |
1.1% |
| Blood Bilirubin Increased |
1.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
67.9% |
| Hiv Infection |
7.1% |
| Induction Of Anaesthesia |
3.6% |
| Anaesthesia |
2.4% |
| Aortic Aneurysm Repair |
2.4% |
| Arterial Therapeutic Procedure |
2.4% |
| Surgery |
2.4% |
| Analgesic Therapy |
1.2% |
| Antibiotic Prophylaxis |
1.2% |
| Aortic Valve Replacement |
1.2% |
| Cardiac Operation |
1.2% |
| Hypertension |
1.2% |
| Intraoperative Care |
1.2% |
| Mitral Valve Replacement |
1.2% |
| Pain |
1.2% |
| Tachycardia |
1.2% |
| Vomiting |
1.2% |
|
| Renal Failure Acute |
25.0% |
| Accidental Overdose |
6.3% |
| Anaphylactic Shock |
6.3% |
| Depression |
6.3% |
| Drug Toxicity |
6.3% |
| Fear |
6.3% |
| Hypertension |
6.3% |
| Liver Disorder |
6.3% |
| Pain |
6.3% |
| Pulmonary Embolism |
6.3% |
| Rash Morbilliform |
6.3% |
| Somnolence |
6.3% |
| Stress Cardiomyopathy |
6.3% |
|
